https://www.ambrosiaplasma.com
A startup company has now launched the first clinical trial in the United States to test the anti ageing benefits of young blood in relatively healthy people. But there's a big caveat: It's a pay-to-participate trial, a type that has raised ethical concerns before, most recently in the stem cell field.
The firm’s co-founder and trial principal investigator is a 31-year-old physician named Jesse Karmazin. His company, Ambrosia in Monterey, California, plans to charge participants $8000 for lab tests and a one-time treatment with young plasma: a single transfusion of a two litre bag.
http://uk.businessinsider.com/young-blood-transfusions-aging-disease-ambrosia-2017-1
No where on website states how young donors are selected.
▼ equineluvr
Please learn the difference between whole blood and plasma.
Your title is misleading, and your ignorance adversely affects your post.
▼ anotherswingingdick
If it's done openly and in accordance with law - good for them,.
There be endless examples of young women getting fame and wealth off of their beauty and youth. Now comes this business which offers the possibility for young men to get in on the action. Cool
▼ Warmoose76
Damn sounds like a bargain.
▼ madhatter67
I'm sure you can get hepatitis cheaper than that!